Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 USD | +16.39% | +27.61% | +38.46% |
05-20 | Sector Update: Health Care Stocks Ease Monday Afternoon | MT |
05-20 | Atara Biotherapeutics Files Biologics License Application for Tabelecleucel with FDA; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.46% | 85.5M | |
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Goldman Sachs Adjusts Atara Biotherapeutics' Price Target to $4 from $5, Keeps Sell Rating